Info Document Actions Print this Ben Hansen, of the Bonkers Institute for Nearly Genuine Research, is alarmed by the over-diagnosis of mental disorders and the widespread use of psychiatric drugs in our society. In this interview, Hansen notes that identification and labeling of consumers is essential to the marketing of drugs, and that “In 1997…
Info INDIANAPOLIS, June 12 (UPI) — Indianapolis-based drug giant Eli Lilly and Co. said Tuesday it settled 900 more product liability claims against its top-selling drug Zyprexa. Lilly settles 900 Zyprexa claims Business, World | June 13, 2007 http://www.imedinews.ge/en/news_read/45372 INDIANAPOLIS, June 12 (UPI) — Indianapolis-based drug giant Eli Lilly and Co. said Tuesday it settled 900…
Info This is a forwarded news release announcing that a group of shareholders of Eli Lilly are seeking to sue officers and directors of the corporation for illegal fraud regarding their psychiatric drug Zyprexa. This Schiffrin Barroway Topaz & Kessler office is just outside of Philadelphia, Pennsylvania Forwarded news release; to read original source click…
Info MindFreedom member Ben Hansen has helped investigate how Eli Lilly has used fraud to gain access to federal Medicaid money for their psychiatric drug Zyprexa. Ben Hansen – also known as “Dr. Bonkers” Breaking News New York Times Exposes Huge Nation-Wide Medicaid Scandal by MindFreedom Michigan In a front page story dated March 23,…
Info Document Actions Print this PharmaTimes reports that an analysis published in the Journal of the American Medical Association saw researchers examine publicly available data for two US states, Vermont and Minnesota, which demonstrated that drugmakers could avoid disclosing details of payments to doctors by classifying the payments as trade secrets, failing to file an…
Info US Congress Investigates Psychiatric Drug Industry Several different USA Congressional committees have been asked to investigate corruption, fraud and cover-up by the psychiatric drug industry. Top Psychiatrist Didn’t Report Drug Makers’ Pay NY Times continues coverage of congressional investigation led by Senator Charles E. Grassley (R-IA) exposing psychiatric drug company corruption, this time involving…
Info Document Actions Print this Congressman Henry Waxman (D-Calif.) is looking into allegations of inappropriate marketing of Zyprexa and other drugs and medical devices, according to Reuters. Waxman is the chairman of a house committee investigating off-label drug marketing by Eli Lilly & Company, AstraZeneca and Cephalon. Off-label use occurs when doctors prescribe products for…
Info Document Actions Print this NY Times covers mixed ruling by judge: Web sites would be free to distribute documents, but very harsh language toward the attorney, doctor and NY times reporter who made the information in the documents available to the public. Judge Rules Drug Documents Must Be Returned to Eli Lilly Date Published:…
Info Document Actions Print this A whistleblower from the US Food and Drug Administration told Congress that they ought to investigate the way the FDA has handled the issue of hazards caused by Eli Lilly’s psychiatric drug Zyprexa. FDA handling of Lilly drug needs probe–scientist Date Published: Feb 13, 2007 08:10 PM Source: Reuters WASHINGTON,…
Info Document Actions Print this MindFreedom’s office is in Eugene, Oregon, and the local daily newspaper has provided coverage about the Zyprexa files controversy. Injunction snares mental health activist Date Published: Feb 15, 2007 03:00 AM Author: Susan Palmer Source: The Register-Guard; Eugene, Oregon, USA A New York judge severely scolded those involved in leaking…